Description: Official healthcare provider website for CAYSTON (aztreonam for inhalation solution). Learn about benefits and risks.
CAYSTON is indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa ( Pa ). Read More Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV 1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia .
EXTENSION PHASE
CAYSTON is contraindicated in patients with a known allergy to aztreonam.